The Oncology Institute, Inc. (NASDAQ:TOI – Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 301,700 shares, an increase of 25.2% from the August 15th total of 240,900 shares. Based on an average daily volume of 144,100 shares, the days-to-cover ratio is currently 2.1 days. Currently, 0.9% of the shares of the company are short sold.
Oncology Institute Price Performance
TOI stock traded down $0.01 during trading on Monday, reaching $0.32. 495 shares of the company were exchanged, compared to its average volume of 151,748. The stock’s 50 day moving average price is $0.43 and its 200 day moving average price is $0.81. The company has a market cap of $23.89 million, a P/E ratio of -0.41 and a beta of 0.61. The company has a debt-to-equity ratio of 3.08, a quick ratio of 2.99 and a current ratio of 3.31. Oncology Institute has a 52-week low of $0.27 and a 52-week high of $2.66.
Oncology Institute (NASDAQ:TOI – Get Free Report) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.07). Oncology Institute had a negative net margin of 18.86% and a negative return on equity of 136.63%. The firm had revenue of $98.58 million for the quarter, compared to analysts’ expectations of $103.31 million. During the same period in the previous year, the company posted ($0.19) EPS. As a group, analysts predict that Oncology Institute will post -0.63 earnings per share for the current fiscal year.
Institutional Trading of Oncology Institute
About Oncology Institute
The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.
Read More
- Five stocks we like better than Oncology Institute
- CD Calculator: Certificate of Deposit Calculator
- Congress Members Are Buying These 3 Hot Stocks
- Best Aerospace Stocks Investing
- Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity
- P/E Ratio Calculation: How to Assess Stocks
- 3 Undervalued Stocks That Are Too Cheap to Ignore Right Now
Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.